The role of metabolic disorders in the progression of renal dysfunction in patients with metabolic syndrome and arterial hypertension

The clinical study enrolled 120 patients, who were hospitalized to the Therapeutic Department of Republican Clinical Hospital No.  5 of Saransk. The patients were divided into 2 groups: Group I (n = 60) included patients with metabolic syndrome; Group II (n = 60)  included patients with arterial hypertension. The paper presents data on the assessment of the functional state of kidneys in the  analysed groups, defines the role of metabolic disorders in the progression of renal dysfunction in patients with metabolic syndrome  and arterial hypertension. It is noted that more pronounced functional changes in the kidneys (microalbuminuria, increased cystatin  C levels, decreased glomerular filtration rate) are detected in patients with arterial hypertension and metabolic syndrome, as compared with patients without metabolic disorders. Cystatin C and microalbuminuria have been shown to be one of the earliest markers of kidney damage in hypertension, especially in combination with metabolic disorders. Cystatin C and microalbuminuria level is  significantly higher in patients with arterial hypertension and metabolic syndrome, as compared with patients with arterial hypertension, who have no metabolic disorders. Significant correlations were found between cystatin C, microalbuminuria levels and lipid  and carbohydrate metabolism in patients with arterial hypertension in combination with metabolic disorders. 

1. Gubergrits N.B., Belyaeva N.V., Klochkov A.E., Lukashevich G.M., Fomenko P.G. Metabolic syndrome: how to avoid polypragmasia? M.: Prima Print, 2017. (In Russ).

2. Adasheva T.V., Demicheva O.Yu. Metabolic syndrome: the basis of pathogenetic therapy. Lechaschi Vrach. 2003;10:24-28. (In Russ).

3. Komissarenko I.A. Metabolic syndrome as a problem of polymorbidity. Consilium Medicum. 2012;1(14):13-17. (In Russ).

4. Mukhin S.A. Reduced glomerular filtration rate is a general population marker of unfavourable prognosis. Terapevtichesky Arkhiv. 2007;6:5-10. (In Russ).

5. Beloborodova A.V., Morozova T.E., Shilov E.M., Andrushchishina T.B. Metabolic syndrome and kidney damage: a rational choice of pharmacotherapy. Lechaschi Vrach. 2010;2:23-28 (In Russ).

6. Chen J., Gu D., Chen C.S. et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol. Dial. Transplant. 2007;22:1100–1106.

7. Ritz E. Metabolic Syndrome and Kidney Disease. Blood Purif. 2008;26:59–62.

8. Ametov A.S., Demidova, T.Yu., Tselikovskaya A.L. Effect of leptin on the regulation of body weight. Serdechnaya Nedostatochnost. 2001;3:135-136. (In Russ).

9. Kryachkova A.A., Savelyeva M.G., Gallyamov M.V. Shestakova I.M. Role of obesity in kidney damage in metabolic syndrome. Nevrologiya i Dializ. 2010;1:34-35. (In Russ).

10. Smirnov A.V., Kayukov I.G., Yesayan A.M., et al. The problem of estimating glomerular filtration rate in modern nephrology: a new indicator - cystatin S. Nefrologia. 2005;9(3):16-27. (In Russ).

11. Mychka V.B., Chazova I.E., Kislyak O.A., Kuznetsova I.V., Litvin A.Yu., Shestakova M.V. Recommendations of experts of the AllRussian Scientific Society of Cardiology for the diagnosis and treatment of metabolic syndrome. Moscow, 2009. (In Russ).

12. Polozova E.I., Mamkina N.N., Seskina A.A., Azizova E.Z., Abramova S.G. Renal disorders in metabolic syndrome. Kardiovaskulyarnaya Terapiya i Profilaktika. 2017; Additional issue (November):82-83. (In Russ).

13. Polozova E.I., Sorokina N.N., Seskina A.A., Puzanova E.V., Azizova E.Z., Abramova S.G. New possibilities for the diagnosis of cardiorenal disorders in metabolic syndrome. Innovations in education and medicine. Proceedings of the 5th All-Russian Scientific and Practical Conference with international participation. Makhachkala, 2018:235-240. (In Russ).

14. Polozova E.I., Sorokina N.N., Chegodaeva L.V., Trokhina I.E., Seskina A.A., Puzanova E.V. The study of renal dysfunction in patients with arterial hypertension and metabolic syndrome. Proceedings of the 6th Eurasian Congress of Cardiology. Moscow 2018:10-11 (In Russ)